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Abstract 
Introduction 
Geriatric assessment (GA) is a multidimensional health assessment of the older person to evaluate 
their physical and cognitive function, comorbidities, nutrition, medications, psychological state, and 
social supports. GA may help oncologists optimise care for older patients with cancer. The aim of this 
study was to explore the views of Australian medical oncologists regarding the incorporation of 
geriatric screening tools, GA and collaboration with geriatricians into routine clinical practice. 
Methods 
Members of the Medical Oncology Group of Australia were invited to complete an online survey that 
evaluated respondent demographics, practice characteristics, treatment decision-making factors, 
use of GA, and access to geriatricians. 
Results 
Sixty-nine respondents identified comorbidities, polypharmacy, and poor functional status as the 
most frequent challenges in caring for older patients with cancer. Physical function, social supports 
and nutrition were the most frequent factors influencing treatment decision-making. The majority of 
respondents perceived value in GA and geriatrician review, although access was a barrier for 
referral. Such services would need to be responsive, providing reports within two weeks for the 
majority of respondents. 
Conclusion 
Despite an emerging evidence base for the potential benefits of GA and collaboration with 
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Introduction 
A growing number of older adults in Australia are being diagnosed with cancer. This is due to a 
combination of an ageing population and increased cancer incidence with age. A detailed 
assessment of the older person’s health status can guide the appraisal of risks and benefits of cancer 
treatment, influence treatment choice and intensity and guide supportive care interventions. 
Assessment of physical and cognitive function, comorbid medical conditions, nutrition, medication 
usage, psychological state, and social supports comprise the core domains of geriatric assessment 
(GA).  
 
Internationally, an increasing number of cancer services have adopted systematic approaches to the 
care of older adults with cancer by incorporating GA and geriatric expertise into assessment and 
decision-making processes1. In comparison, GA and geriatric oncology services remain confined to a 
small number of cancer centres in Australia1. 
 
Australia has a universal healthcare system for permanent residents covering medical consultations, 
public hospital admissions and subsidised pharmaceuticals. In 2016, there were 619 geriatricians in 
Australia with an average of 2.4 clinicians per 100,000 population2. Geriatric medicine and cancer 
services, although readily available within both public and private hospitals, often lack a formalised 
approach to collaboration. To date, there is limited information on Australian oncologists’ views and 
experiences of geriatric oncology. 
 
This study aimed to explore the views of Australian medical oncologists regarding the perception of, 
and barriers to the incorporation of geriatric screening tools, GA and collaboration with geriatricians 
in routine clinical practice. 
 
Methods 
A cross-sectional survey was developed by a multidisciplinary national expert steering group on 
behalf of the Clinical Oncology Society of Australia’s Geriatric Oncology group, comprising medical 
and nursing representatives from medical oncology, geriatric medicine, and palliative care. The 
online survey, based on a literature review and expert opinion, comprised 30 questions covering: (i) 
respondent characteristics, clinical practice environment and patient population; (ii) challenges and 
treatment decision-making factors in the management of older patients with cancer; and (iii) 
benefits of and barriers to the implementation of GA or geriatrician review in cancer care for older 
patients.  
For the purpose of this study, geriatric screening tools were defined as brief tools used to identify 
older patients with cancer who are likely to benefit from a more detailed assessment. Geriatric 
assessment was defined as a panel of assessment tools covering relevant domains for the older 
patient with cancer, which identify domains of concern potentially requiring further assessment and 
intervention. This was distinct from a geriatrician review, in which a geriatrician assesses the older 
person, contextualises information to the patient’s situation, and makes recommendations to guide 
interventions. These definitions were presented to respondents in relevant sections of the survey. 
An invitation to participate in the online survey was emailed to members of the Medical Oncology 
Group of Australia (MOGA) in June 2015, comprising 450 oncologists and 172 trainees, representing 
approximately 90% of medical oncologists in the region. Two reminders were sent before the survey 
closed in November 2015 to encourage participation.  
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The survey was completed by participants using SurveyMonkey (SurveyMonkey Inc., San Mateo, 
California, USA). Descriptive statistical analysis was performed using SPSS version 24 (IBM Corp., 
Armonk, NY). A coding schema was developed to categorise responses to open-ended questions into 
broad themes. Group comparisons of respondent characteristics were performed for the following 
three questions: ‘Do you or your service routinely screen your older cancer patients?’; ‘Have you 
ever referred a patient for geriatric assessment?’; and, ‘Have you ever referred a patient for a 
geriatrician review?’.  
This study was approved by the University of Technology Sydney’s Human Research Ethics 
Committee (05 May 2015; Approval Number: 2015000122). 
Results 
Sixty-nine oncologists completed the survey (response rate 11%). Table 1 outlines respondent 
characteristics. Respondents reported older patients constituted a substantial portion of their 
practice, with 33% (23/69) estimating 51-75% of their patients were over 70 years, and a further 
54% estimating 25-50% of patients were over 70 years. Fifty-nine percent of respondents reported 
an interest in geriatric oncology. Allied health services were ‘readily’ or ‘somewhat’ available for 
over 95%. No respondent characteristics (years of practice, practice type, location) were associated 
with a higher likelihood of conducting geriatric screening, or referring for GA or geriatrician review. 
Decision-making for older patients  
Comorbidities, polypharmacy, poor functional status and treatment toxicity were the most 
frequently identified challenges when caring for older patients with cancer (Figure 1). Physical 
function, living circumstance/social supports, and nutritional status were most frequently identified 
as important treatment decision factors for older patients with cancer (Figure 2). 
Geriatric screening 
Only 19% (13/69) of respondents used geriatric screening tools in routine practice. Of these 
respondents, screening was primarily triggered by age (77%), most commonly an age of 70 years 
(80%). The remainder screened any patient they suspected to be frail. Screening tools used are 
outlined in Figure 3, with the Mini-Mental State Examination most commonly used. 
Geriatric assessment 
The majority of respondents identified that GA added to clinical assessment (71%) and influenced 
clinical decision-making (65%) (Figure 4). GA had been requested by 56% of respondents. Access to 
(40%) and timeliness of GA (47%) were identified as barriers for the 30 respondents who had not 
requested GA, whilst 23% of these saw no need for GA.  
Geriatrician review 
Access to timely geriatrician review was desired by 74% (52/69) of respondents. However, only 30% 
had referred to a geriatrician, of whom 90% had referred less than 10 patients in the last year. 
Geriatrician review was identified as adding to clinical assessment (73%) and influencing clinical 
assessment (66%) (Figure 4). 
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Issues triggering referral to a geriatrician included concerns regarding: cognition and decision-
making capacity 51% (23/45), general health and frailty (24%), assessment and management of 
comorbidities (24%), functional assessment and optimisation (22%) and medication review (16%). 
If available, 57% (39/68) of respondents estimated referring less than 25% of their patients aged 
over 70 to a geriatrician, with 25% of respondents estimating referring 25-50%. The remainder (17%) 
estimated referring more than half of their older patients. Referrals would generally be at diagnosis 
(28%) or prior to a treatment decision (62%). 
Importantly, a report from a GA or geriatrician would ideally be finalised within one week for 60% 
(41/68) of respondents, or two weeks for 37%. A written report was preferred by the majority of 
respondents (78%), although a verbal report (26%) or as part of a multidisciplinary discussion (56%) 
were acceptable for many.  
Barriers  
Identified barriers to GA or geriatrician review are presented in Figure 5. The top three identified 
barriers to GA or geriatrician review were: time required to perform GA (75%), lack of geriatrician 
(63%), and lack of services available to perform GA (62%) (Figure 5). 
Discussion 
This study identified a perception that GA and/or geriatrician review would improve clinical 
assessment and influence decision-making amongst participating medical oncologists. These findings 
are similar to other international studies where the vast majority (75-95%) of cancer specialists 
believe GA is beneficial3-6. 
In our study, comorbidities, polypharmacy, poor functional status and treatment toxicity were the 
most commonly identified challenges when caring for older patients with cancer, similar to those 
identified in a 2006 survey of Canadian cancer specialists7. However, polypharmacy ranked first in 
our survey, compared to eighth in Canada, perhaps reflecting increasing awareness of the risks of 
polypharmacy.  
Patient factors that influenced treatment decisions included comorbidities, physical function and 
patient preferences, whereas treatment factors that most frequently influenced treatment decisions 
were benefits, toxicity, and prognosis, similar to those found in Canadian and Singaporean surveys5 7.  
Factors predictive of chemotherapy toxicity in older patients, as identified in two scoring systems, 
include cognition, nutrition, falls, functional status and age, which are also key components of the 
GA8 9. Whilst physical function is now widely recognised by oncologists as an important GA domain, 
factors such as cognition, nutrition and falls appear less commonly recognised. This suggests ongoing 
education is required for routine incorporation of these domains into oncological assessment. 
However, in this survey, oncologists would most commonly consult a geriatrician about cognition, 
followed by comorbidities, general health, and physical function.  
Access to geriatric expertise remains a major barrier for older adults with cancer in Australia, similar 
to surveys from other high-income countries4 5 7. In our study, despite the majority of respondents 
perceiving that GA improved clinical assessment and treatment decisions, 70% of respondents had 
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never referred to a geriatrician. However, GA performed by allied health may help address this issue 
by identifying patients who would benefit from a detailed geriatrician review, thus potentially 
improving accessibility and reducing implementation costs. The majority of GA or geriatrician 
reviews in oncology were required within one week, and almost all within two, as these reviews are 
often required at time-critical periods, such as at diagnosis or time of treatment decisions to inform 
whether modified cancer treatment is required. However, GA may also inform supportive care 
interventions, which may not be as time-critical and can occur in parallel with oncological decision-
making and treatment. In Belgium, 59% of GA is performed the same day as the oncological 
assessment, with over 80% conducted within four days10. This difference likely reflects a systematic 
approach facilitating rapid GA and increased use of integrated inpatient oncological GA processes. 
The design of a GA or geriatrician consultation service for older patients with cancer must account 
for the need for quick response times.  
Whilst the majority of respondents preferred the GA or geriatrician review report in writing, over 
half welcomed it as being part of a multidisciplinary discussion. Care planned by a multidisciplinary 
team facilitates collaboration and recognition of GA domains and higher rates of treatment 
modification11 12. 
Concerns have been raised about the feasibility of geriatric oncology services without additional 
resources. A German survey found that whilst 95% thought that GA was meaningful, 30% thought it 
impracticable6. Similarly in a Singaporean survey, 28% questioned the feasibility of such a service5. 
Feasibility issues could be addressed by examining alternative models of geriatric oncology, 
developing partnerships between existing oncology and geriatric services, using screening to identify 
vulnerable individuals for comprehensive assessment, and demonstrating the value of such services 
to stakeholders.  
Even with a systematic approach to geriatric oncology such as in Belgium, the incorporation of GA 
and interventions into the care of older patients with cancer is challenging. A recent Belgian survey 
identified that whilst a substantial proportion of patients receive GA and have recommendations 
implemented, the availability and incorporation of GA into multidisciplinary discussions and 
treatment decisions occurs only less than 20% of the time10.  
Limitations 
Despite the low survey response rate, the findings are consistent with surveys conducted in other 
countries. Respondents likely had limited direct exposure to geriatric oncology services given the 
small number of services in Australia. Conversely, it is likely that there is a degree of responder bias, 
with those with an interest in geriatric oncology likely over-represented in the sample. 
Implications for future practice/service design 
This study has identified a desire and perceived need for increased geriatric oncology services and 
collaboration with geriatricians amongst respondents. However, the low response rate may also 
reflect an ambivalence towards geriatric oncology amongst oncologists, highlighting the need for 
ongoing awareness-raising and generation of supporting evidence. The design and provision of 
geriatric oncology services must address barriers identified in this research, in particular the 
availability of GA and geriatric expertise in a timely manner. Closer collaboration between 
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oncologists and geriatric expertise is required to embed such services into routine practice. Given 
that geriatric medicine services and cancer care services are often co-located within Australian 
hospitals, utilisation of existing resources may be possible. Incorporation of geriatrics into oncology 
training, and vice versa, may build expertise into the future workforce, and should be considered by 
the respective training organisations. Dual training in geriatric medicine and oncology has been 
undertaken by a small number of clinicians in Australia. Whilst it will not be feasible for all older 
adults with cancer to see a dual-trained geriatric oncologist, these highly skilled specialists are ideally 
placed to guide future research and education in the field. 
The Clinical Oncology Society of Australia is currently developing geriatric oncology guidelines to 
support clinicians and services to design and practice in accordance with current best evidence. 
Implementation of these guidelines could be supported by review of the Australian Medicare 
Benefits Schedule - GA is currently not reimbursed by Medicare but future reforms may support the 
incorporation of GA and other multidisciplinary care into oncological practice. The preferred model 
of care may be best addressed locally, tailored to the local availability of geriatric expertise and 
funding models. Ongoing research is required to build evidence regarding the merits of differing 
models of care and the benefits of GA-driven interventions in this population. 
 
Conclusion 
In this survey of medical oncologists, geriatric assessment of older patients with cancer and 
collaboration with geriatricians was welcomed. However, access to appropriate expertise was a 
substantial barrier. Furthermore, such services need to occur in a timely manner and work in close 
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Table 1. Respondent characteristics (n=69) 
  n* (%) 
Years of practice as specialist oncologist In training 14 (20) 
 0-10 years 27 (39) 
 11-20 years 12 (17) 
 21-30 years 11 (16) 
 30+ years 5 (7) 
   
Practice type (majority) Public 41 (59) 
 Private 15 (22) 
 Academic 7 (10) 
 Other 6 (9) 
   
 Full-time 44 (64) 
 Part-time 25 (36) 
   
Location Metropolitan 62 (90) 
 Regional 6 (9) 
 Remote 1 (1) 
*Percentanges may not add up to 100% due to rounding  
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Figure 1. Challenging factors in the management of older patients with cancer (n=69). 
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Figure 2. Factors considered important when making treatment decisions in patients with cancer 
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Figure 3. Currently used geriatric screening tools (n=13). 
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Figure 4. Impact of geriatric assessment and geriatrician review on medical oncologist’s clinical 
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Figure 5. Barriers to implementation of geriatric assessment or geriatrician review of older patients 
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